ChinaBio® Today Articles

Welcome to the ChinaBio® Today store. As a service to our readers, we offer access to individual articles for only $5.00 (USD) each.  Of course, a subscription is only $20/mo, so you may prefer to subscribe.  If so, click on Subscribe in the menu.

Browse


All Products

Viewing 3316 - 3330 of 5996 products
Arcus Completes $107 Million C Round with China VC Participation
$5.00
Available
Pfizer Sells 49% Stake in China Generic Drug JV
$5.00
Available
Valeant Sells Obagi to Fund that Includes China Regenerative Medicine
$5.00
Available
Ark Biosciences Partners with Calibr on Novel COPD Treatment
$5.00
Available
Genovis Finds Second China Distribution Partner for Enzyme Portfolio
$5.00
Available
US Denies Approval for Creat's $1.5 Billion Acquisition of Germany's Biotest
$5.00
Available
Cellular Biomedicine Opens Shanghai CAR-T Facility
$5.00
Available
Zhejiang Huahai In-licenses Immuno-Oncology Drug in $65 Million Deal
$5.00
Available
EOC, an Eddingpharm Spin-out, Closes $32 Million B Round for Oncology Assets
$5.00
Available
Guangzhou's AnchorDx Raises $28 Million for Precision Oncology Offerings
$5.00
Available
Luye Pharma Leads $11.2 Million Funding of Chicago's Exicure
$5.00
Available
Guangzhou Pharma May Form China Generics JV with Teva Pharma
$5.00
Available
WuXi Biologics Partners with Pall to Reduce mAb Production Costs
$5.00
Available
Shanghai Fosun To Take Control of Taiwan's Henlix for $98 Million
$5.00
Available
iPharma in-licenses Global Rights to FAK inhibitor from Boehringer Ingelheim
$5.00
Available